Investors focused on the Medical space have likely heard of Trillium Therapeutics (TRIL), but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the ...

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in ...

The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research ...

Today’s proving to be a great start to the week for investors in Trillium (NASDAQ:TRIL). The company is being acquired by one of the largest and most well-known biopharmaceutical companies today. As ...

Trillium Therapeutics Inc. TRIL was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a ...